These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15614820)

  • 1. The use of 13C labeling to enhance the sensitivity of 13C solid-state CPMAS NMR to study polymorphism in low dose solid formulations.
    Booy KJ; Wiegerinck P; Vader J; Kaspersen F; Lambregts D; Vromans H; Kellenbach E
    J Pharm Sci; 2005 Feb; 94(2):458-63. PubMed ID: 15614820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-state NMR studies of pharmaceutical solids in polymer matrices.
    Lubach JW; Padden BE; Winslow SL; Salsbury JS; Masters DB; Topp EM; Munson EJ
    Anal Bioanal Chem; 2004 Mar; 378(6):1504-10. PubMed ID: 15214410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Applications of Relaxation Filter-Selective Signal Excitation Methods for ¹⁹F Solid-State Nuclear Magnetic Resonance: Case Study With Atorvastatin in Dosage Formulation.
    Asada MN; Nemoto T; Mimura H
    J Pharm Sci; 2016 Mar; 105(3):1233-8. PubMed ID: 26886305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of 13C CPMAS NMR for qualitative and quantitative characterization of carvedilol and its commercial formulations.
    Zielińska-Pisklak M; Pisklak DM; Wawer I
    J Pharm Sci; 2012 May; 101(5):1763-72. PubMed ID: 22331650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H, 13C, 15N NMR analysis of sildenafil base and citrate (Viagra) in solution, solid state and pharmaceutical dosage forms.
    Wawer I; Pisklak M; Chilmonczyk Z
    J Pharm Biomed Anal; 2005 Aug; 38(5):865-70. PubMed ID: 16087048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of crystalline and amorphous forms of anhydrous neotame using 13C CPMAS NMR spectroscopy.
    Offerdahl TJ; Salsbury JS; Dong Z; Grant DJ; Schroeder SA; Prakash I; Gorman EM; Barich DH; Munson EJ
    J Pharm Sci; 2005 Dec; 94(12):2591-605. PubMed ID: 16258988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ¹³C cross-polarization magic-angle spinning nuclear magnetic resonance analysis of the solid drug forms with low concentration of an active ingredient-propranolol case.
    Pisklak DM; Zielińska-Pisklak M; Szeleszczuk L; Wawer I
    J Pharm Biomed Anal; 2014 May; 93():68-72. PubMed ID: 23911072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved solid-state NMR quantifications of active principles in pharmaceutical formulations.
    Sanchez S; Ziarelli F; Viel S; Delaurent C; Caldarelli S
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):683-7. PubMed ID: 18479881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of remote protonation on 13C CPMAS NMR quantitation of charred and uncharred wood.
    Smernik RJ; Baldock JA; Oades JM
    Solid State Nucl Magn Reson; 2002 Aug; 22(1):71-82. PubMed ID: 12421090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing anhydrous and hydrous forms of an active pharmaceutical ingredient in a tablet formulation using solid-state NMR spectroscopy.
    Griffin JM; Martin DR; Brown SP
    Angew Chem Int Ed Engl; 2007; 46(42):8036-8. PubMed ID: 17847137
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state (13)C CPMAS NMR spectroscopy.
    Virtanen T; Maunu SL
    Int J Pharm; 2010 Jul; 394(1-2):18-25. PubMed ID: 20416365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 19F solid-state NMR spectroscopic investigation of crystalline and amorphous forms of a selective muscarinic M3 receptor antagonist, in both bulk and pharmaceutical dosage form samples.
    Wenslow RM
    Drug Dev Ind Pharm; 2002 May; 28(5):555-61. PubMed ID: 12098844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-state nuclear magnetic resonance (NMR) spectra of pharmaceutical dosage forms.
    Saindon PJ; Cauchon NS; Sutton PA; Chang CJ; Peck GE; Byrn SR
    Pharm Res; 1993 Feb; 10(2):197-203. PubMed ID: 8456065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMR.
    Apperley DC; Forster AH; Fournier R; Harris RK; Hodgkinson P; Lancaster RW; Rades T
    Magn Reson Chem; 2005 Nov; 43(11):881-92. PubMed ID: 16059964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and analysis of drugs in the solid state by 13C CPMAS NMR: suxamethonium chloride and hydrocortisonum (Corhydron).
    Paradowska K; Wolniak M; Fijałek Z; Wawer I
    Acta Pol Pharm; 2008; 65(3):295-301. PubMed ID: 18646548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Characterization of Formulated Pharmaceuticals Using Fast MAS
    Hirsh DA; Wijesekara AV; Carnahan SL; Hung I; Lubach JW; Nagapudi K; Rossini AJ
    Mol Pharm; 2019 Jul; 16(7):3121-3132. PubMed ID: 31095913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-state NMR as an effective method of polymorphic analysis: solid dosage forms of clopidogrel hydrogensulfate.
    Pindelska E; Szeleszczuk L; Pisklak DM; Mazurek A; Kolodziejski W
    J Pharm Sci; 2015 Jan; 104(1):106-13. PubMed ID: 25393324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and conformational study of peptides containing glycine and alanine residues by 13C CPMAS NMR spectroscopy in solid state.
    Jagannathan NR; Suryaprakash N
    Indian J Biochem Biophys; 1997 Jun; 34(3):235-40. PubMed ID: 9425741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligomeric complexes of some heteroaromatic ligands and aromatic diamines with rhodium and molybdenum tetracarboxylates: 13C and 15N CPMAS NMR and density functional theory studies.
    Leniak A; Kamieński B; Jaźwiński J
    Magn Reson Chem; 2015 May; 53(5):344-52. PubMed ID: 25614975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the effects of pharmaceutical processing upon solid-state NMR relaxation times and implications to solid-state formulation stability.
    Lubach JW; Xu D; Segmuller BE; Munson EJ
    J Pharm Sci; 2007 Apr; 96(4):777-87. PubMed ID: 17238201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.